B1371012 (FL)

B1371012 (FL)

An open-label phase 1b study of PF-04449913 (Glasdegib) in combination with azacitidine in patients with previously untreated higher-risk myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), or chronic myelomonocytic leukemia (CMML)

Currently on hold

Study treatments


Inclusion criteria


Exclusion criteria


Participating sites

Link